-+ 0.00%
-+ 0.00%
-+ 0.00%

HSBC Downgrades Amgen to Hold, Lowers Price Target to $425

Benzinga·09/10/2026 14:13:59
Listen to the news
HSBC analyst Morten Herholdt downgrades Amgen (NASDAQ:AMGN) from Buy to Hold and lowers the price target from $445 to $425.